Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

Go back to Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
(NASDAQ: PLRX) Delayed: 1.16 --0 (-0%)
Previous Close $1.16    52 Week High
Open $1.17    52 Week Low
Day High $1.18    P/E N/A 
Day Low $1.14    EPS
Volume 227,794